Re-Irradiation for Locally Recurrent Lung Cancer: A Single Center Retrospective Analysis.
PTV
local recurrence
lung cancer
overall survival
reirradiation
Journal
Current oncology (Toronto, Ont.)
ISSN: 1718-7729
Titre abrégé: Curr Oncol
Pays: Switzerland
ID NLM: 9502503
Informations de publication
Date de publication:
13 05 2021
13 05 2021
Historique:
received:
26
03
2021
revised:
07
05
2021
accepted:
11
05
2021
entrez:
2
6
2021
pubmed:
3
6
2021
medline:
25
9
2021
Statut:
epublish
Résumé
The treatment of locally recurrent lung cancer is a major challenge for radiation-oncologists, especially with data on high-dose reirradiation being limited to small retrospective studies. The aim of the present study is to assess overall survival (OS) for patients with locally recurrent lung cancer after high-dose thoracic reirradiation. Thirty-nine patients who were re-irradiated for lung cancer relapse between October 2013 and February 2019 were eligible for the current retrospective analysis. All patients were re-irradiated with curative intent for in-field tumor recurrence. The diagnostic work-up included a mandatory
Identifiants
pubmed: 34068043
pii: curroncol28030170
doi: 10.3390/curroncol28030170
pmc: PMC8161822
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1835-1846Références
Clin Oncol (R Coll Radiol). 2018 Feb;30(2):101-109
pubmed: 29223641
Int J Radiat Oncol Biol Phys. 2010 Dec 1;78(5):1387-93
pubmed: 20381271
Radiother Oncol. 2014 Mar;110(3):505-10
pubmed: 24444530
Thorac Cancer. 2020 Feb;11(2):369-378
pubmed: 31855325
Strahlenther Onkol. 2018 Oct;194(10):886-893
pubmed: 30014235
Lung Cancer. 2014 Mar;83(3):356-62
pubmed: 24433824
Int J Clin Oncol. 2005 Aug;10(4):247-50
pubmed: 16136369
Int J Radiat Oncol Biol Phys. 1989 Nov;17(5):993-1005
pubmed: 2808062
Strahlenther Onkol. 2020 Apr;196(4):315-324
pubmed: 32002566
J BUON. 2009 Jan-Mar;14(1):33-40
pubmed: 19373944
Ann Oncol. 2019 May 1;30(5):781-787
pubmed: 30887043
Int J Radiat Oncol Biol Phys. 2010 Mar 1;76(3 Suppl):S77-85
pubmed: 20171522
Int J Radiat Oncol Biol Phys. 2004 Nov 15;60(4):1241-56
pubmed: 15519797
Anticancer Res. 2013 Dec;33(12):5649-53
pubmed: 24324112
Strahlenther Onkol. 2019 Aug;195(8):725-733
pubmed: 30937509
Radiat Oncol. 2013 Mar 05;8:49
pubmed: 23497555
Radiother Oncol. 2013 Mar;106(3):327-32
pubmed: 23453540
Int J Radiat Oncol Biol Phys. 2003 Dec 1;57(5):1345-50
pubmed: 14630272
Int J Radiat Oncol Biol Phys. 2011 Jul 15;80(4):969-77
pubmed: 21489714
Cancer. 1982 Mar 1;49(5):865-8
pubmed: 7059924
Clin Lung Cancer. 2008 Jul;9(4):217-21
pubmed: 18650169
Radiat Oncol. 2016 Aug 02;11:104
pubmed: 27485533
Lung Cancer. 2012 Jul;77(1):140-5
pubmed: 22445656
Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):808-15
pubmed: 26831903
Int J Radiat Oncol Biol Phys. 2012 Nov 15;84(4):1017-23
pubmed: 22543216
Radiother Oncol. 2011 May;99(2):235-9
pubmed: 21497928
Am J Clin Oncol. 2014 Feb;37(1):70-6
pubmed: 23357968
Lancet Oncol. 2014 Dec;15(13):e620-e624
pubmed: 25456380
Strahlenther Onkol. 2017 Apr;193(4):315-323
pubmed: 28116446
Radiat Oncol. 2013 Apr 25;8:99
pubmed: 23617949
Int J Radiat Oncol Biol Phys. 2002 Feb 1;52(2):390-6
pubmed: 11872284
Am J Clin Oncol. 1993 Dec;16(6):482-8
pubmed: 8256761
Radiother Oncol. 2013 Jun;107(3):423-7
pubmed: 23647748